Patients with seropositive RA on stable DMARD therapy showed a CVD risk comparable with that of the general population, unlike those whose treatment regimen was not stable.
Advanced systems for measuring patient-reported outcomes can help improve care of patients with rheumatoid arthritis and ...
Dupilumab Linked to Increased Risk of Cutaneous T Cell Lymphoma in Atopic Dermatitis Patients: Study
Researchers have found that the use of dupilumab, a human monoclonal antibody targeting the IL-4 alpha receptor, is ...
EMA committee adopts positive opinion for Biogen’s Tofidence, a biosimilar monoclonal antibody referencing Roactemra: Cambridge, Massachusetts Saturday, April 27, 2024, 17:00 Hr ...
Request To Download Free Sample of This Strategic ...
CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the ...
CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE to the reference product ROACTEMRA® CAMBRIDGE, Mass., April 25, 2024Inc. (Nasdaq: BIIB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback